[Gapkol--a new osteoplastic material].
Hapcol, a new osteoplastic material, representing a biological composition on the basis of a natural biopolymer collagen with biologically compatible osteotropic mineral hydroxyapatite has been developed and allowed for clinical use. It is intended for use in dentistry in surgical treatment of periodontal diseases, deformations of the abutment tissues of the face, filling of bone defects after cystectomy, surgery for bone plasty, etc. Hapcol is characterized by antiinflammatory action, stimulates repair osteogenesis and collagenogenesis. Joint stock company Polistom starts commercial manufacture of the new material.
Aboiants
R K
RK
Istranov
L P
LP
Shekhter
A B
AB
Rudenko
T G
TG
Istranova
E V
EV
Antipas
D B
DB
Kurdiumov
S G
SG
D000818:Animals; D001704:Biopolymers / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001861:Bone Regeneration / Q000187:drug effects; D018786:Bone Substitutes / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D003094:Collagen / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D003764:Dental Materials / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D004338:Drug Combinations; D004341:Drug Evaluation; D017886:Durapatite / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D005269:Femur / Q000187:drug effects / Q000473:pathology; D006801:Humans; D008422:Materials Testing / Q000379:methods; D010514:Periodontal Pocket / Q000601:surgery; D051381:Rats; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects
D001704:Biopolymers; D018786:Bone Substitutes; D003764:Dental Materials; D004338:Drug Combinations; C104010:Hapcol; D003094:Collagen; D017886:Durapatite
Gapkol--novyĭ osteoplasticheskiĭ material.